Steven L. Roberds, Ph.D.

Chief Scientific Officer, Tuberous Sclerosis Alliance

Steven L. Roberds, Ph.D., is the Chief Scientific Officer of the Tuberous Sclerosis Alliance in Silver Spring, Maryland, a national voluntary health organization dedicated to finding a cure for and improving the lives of those affected by tuberous sclerosis complex (TSC), a genetic disorder that causes non-malignant tumors in the brain, eyes, heart, kidney, skin, and other organs. Since joining the TS Alliance in 2011, he has worked with scientists, clinicians, and members of industry, academia, and government agencies to advance research and treatments for TSC. Previously, Dr. Roberds served as an associate research fellow at Pfizer Global Research & Development and as a postdoctoral fellow in the Department of Physiology and Biophysics at the University of Iowa, Iowa City. He received his Ph.D. in pharmacology at Vanderbilt University School of Medicine in Nashville, Tennessee.